Technical Transition Services. During the Transition Period, Surface will perform certain transition and research services in connection with the Development and Manufacture of Licensed Antibodies and Licensed Products (“Technical Transition Services”), as more fully detailed in the Transition Plan.
Appears in 2 contracts
Sources: License Agreement (Coherus BioSciences, Inc.), License Agreement (Surface Oncology, Inc.)